The health status of the President of the Republic, Laurentino CortizoShe was diagnosed with intermediate-risk myelodysplastic syndrome, raising hopes because of her importance in her work, nearly two years before the end of her mandate.
It is a disease that can affect another three cell lines in a patient (red blood cells, white blood cells and platelets) and can turn into leukemia in the highest-risk cases, the doctor explained. Dimas Quill of the Hematology Oncology Center of Panama.
The higher the risk, the less time in which the syndrome can turn into leukemia, which dramatically alters life expectancy, which can be estimated at less than six months.
Myelodysplasia (MDS) It is the structural change of bone marrow cells that gives rise to blood cells. Normally, all people develop dysplasia in some cells of the bone marrow as we get older, and it is estimated that most patients over the age of 70 will have changes, but this does not mean that they Will develop myelodysplastic syndrome.
Myelodysplastic syndrome occurs when damage compromises the largest number of cells or blood factories. If it affects red blood cells Anemia occurs, the patient will feel tired, tired, restless, with palpitations, difficulty in breathing or performing certain physical activities; If it compromises the platelet chain There will be manifestations of bleeding and bruising; If it compromises white blood cells You will be at risk of infection.
There are few effective therapeutic options for this disease, there are drugs that control it but rarely cure it. Therefore, bone marrow transplants are offered to patients in good health.
Low-risk patients may rely on stimulants or medications to help. red blood cell productionBut as it progresses to intermediate and high risk, treatments are more aggressive.’
According to international publications, the prevalence is one patient or more per 100 thousand inhabitants per year.
The year is average in Panama, making it one of the most common hematological diseases.
any kind of patient intermediate riskAs is the case with Cortizo, may respond to oral or subcutaneous treatment, or may necessarily lead to an implant, he explained.
See also: Panama reports 15,285 active cases of COVID-19, and four new deaths
who believes that The intermediate risk patient is in the gray area, And its treatment will rely on specialized molecular studies to guarantee the best survival from the disease without compromising quality of life.
experts recommended President Cortizo a second assessment with examinations of molecular Biology, Which will be held in Houston, Texas. The final examination on the President showed a decrease in hemoglobin and white blood cell counts.
Quiel also cited the adverse effects of legitimate treatment for myelodysplastic syndrome. Aggressive treatments such as chemotherapy usually result in hair loss, nausea, vomiting, decreased survival, difficulty leading a normal life, disability, and shorter hospital stays.
In the meantime, less invasive treatments will allow for a better quality of life, with few manageable side effects that won’t disrupt your daily activities, he explained.
Official sources indicated that Cortizo is subject to regular and complete blood tests every six months.
MDS in Panama
Panama does not have clear data incidence or prevalence of diseaseAnd as in many countries, it is handled with international references, Quill indicated.
The country has the technologies to conduct genetic studies on chromosomes and bone marrow, but not with molecular panels. He says there are teams in the country to take them out that still require external verification. day to day, Panama sends nuclear panels to be built in the United States.
Treatment is expensive though Social Security Fund and Oncology Institute They have few drugs, the option of transplant, but the database is too small to guarantee a donor. Other drugs are not in public facilities, some are not registered in Panama and others will be dependent on imports, said an expert from the Hemato-Oncology Center in Panama.
See what’s on our YouTube channel!